Robin Steigerwald

Martinsried, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.

A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.

Journal: Frontiers in immunology
Published: September 01, 2020

Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.

Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.

Journal: Vaccine
Published: July 02, 2019

Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Journal: PloS one
Published: April 25, 2018

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Journal: PloS one
Published: October 31, 2017

Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.

Protective efficacy of monovalent and trivalent recombinant MVA-based vaccines against three encephalitic alphaviruses.

Journal: Vaccine
Published: July 26, 2017

Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Journal: Journal of virology
Published: March 02, 2017

IFN-γ Primes Keratinocytes for HSV-1-Induced Inflammasome Activation.

IFN-γ Primes Keratinocytes for HSV-1-Induced Inflammasome Activation.

Journal: The Journal of investigative dermatology
Published: May 05, 2015

A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.

A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses.

Journal: PloS one
Published: April 09, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026